Duchenne’s Patient Ryan Benton Discusses His Experience with Stem Cell Therapy

Ryan Benton is the first patient in the United States to receive human umbilical cord-derived mesenchymal stem cell therapy for Duchenne’s muscular dystrophy. The US FDA granted Ryan this trial under compassionate use. Ryan first began treatments at the Stem Cell Institute in Panama before being able to receive treatments in his hometown of Wichita,…

Muscular Dystrophy Sufferers Hope New Treatment Can Answer Prayers

Adult stem cell therapy has been used for many diseases including heart failure, liver failure, stroke, multiple sclerosis, and even drug resistant tuberculosis. The biological basis for how stem cell therapy works seems to be two-fold. On the one hand, the stem cells appear to have the ability to become new tissues, on the other…